2004•JAMARequires access

West Nile Virus Trials

Tracy Hampton

Open publisher page 1 citations

Abstract

The National Institute of Allergy and Infectious Diseases is expanding its clinical trial of an experimental West Nile virus (WNV) treatment. The trial opened at 36 sites last September, and it is expected to add about 24 new sites this summer.

About this research paper

What this paper is about

The National Institute of Allergy and Infectious Diseases is expanding its clinical trial of an experimental West Nile virus (WNV) treatment. The trial opened at 36 sites last September, and it is expected to add about 24 new sites this summer.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The National Institute of Allergy and Infectious Diseases is expanding its clinical trial of an experimental West Nile virus (WNV) treatment. The trial opened at 36 sites last September, and it is expected to add about 24 new sites this summer.

Key concepts: West Nile virus, Medicine, Virology, Clinical trial, Virus, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
West Nile Virus Trials — Research Paper | ScholarLens